Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas
NCT ID: NCT02350452
Last Updated: 2016-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2015-01-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to compare the antimüllerian marker (AMH) and antral follicular count (AFC) , with the most common serological markers of ovarian reserve. The investigators intend to confirm their clinical utility in the assessment of ovarian function, and to promote their use in predicting decreased ovarian reserve.
The work therefore moreover arises the objective to validate the bibliographic data about using the laser for haemostasis after stripping endometriomas, to amplify knowledge available in the literature on the surgical treatment of ovarian endometriomas and on the diode laser application in minimally invasive surgery, appraising the trend of AFC and AMH levels and the possible surgical implications on fertility .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
NCT06219044
The Impact on Ovarian Reserve of Ovarian Cystectomy Versus Laser Vaporization in the Treatment of Ovarian Endometrioma: a Randomized Clinical Trial
NCT03227640
Effect of Management of the Endometrioma on Ovarian Reserve
NCT05637073
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence
NCT01092494
Impact on Ovarian Reserve According to the Type of Ovarian Endometrioma Excision: Laser Versus Conventional Cystectomy
NCT03826355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diode laser coagulation
Diode laser coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Diode laser coagulation
Diode laser coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Bipolar coaugulation
Bipolar coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Bipolar coagulation
Bipolar coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diode laser coagulation
Diode laser coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Bipolar coagulation
Bipolar coagulation of inner lining of ovarian endometrioma after laparoscopic cystectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral endometrioma greater than 35 mm
* no gynecological surgery 3-6 months before surgery
* no hormonal therapy 1 month before surgery
Exclusion Criteria
* hormone therapy in the month before the current surgery
* coagulation disorders
* ongoing pregnancy
* pelvic inflammatory disease
* malignant disorders
* cysts otherwise
* Gonadotropin-releasing hormone analogues or contraceptive therapy during the follow-up
* BMI≥ 30 kg/m2
* endocrinological disorders
* unable or unwilling to give written consent
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Foggia
OTHER
University of Cagliari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefano Angioni
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cagliari,Obstetrics and Gynecological Department,
Monserrato, Cagliari, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ENDOLASER01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.